Tuesday, February 26, 2019

Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug

Biotech company Amgen Inc said on Monday a U.S. jury confirmed the validity of patents on its cholesterol drug Repatha, rejecting a challenge by Regeneron Pharmaceuticals Inc and Sanofi SA.


from Reuters: Health News https://ift.tt/2T0QQaI
By at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)